Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 6 of 37
Health
Omicron has all but wiped out the more deadly Delta strain—but that’s not necessarily a good thing
By
Christiaan Hetzner
March 31, 2022
Newsletters
Business leaders challenge fellow CEOs to raise their game on net-zero commitments
By
Bernhard Warner
and
Alan Murray
March 31, 2022
Health
FDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By
Lauran Neergaard
,
Matthew Perrone
and
The Associated Press
March 29, 2022
Newsletters
The pandemic has accelerated innovation across industries—particularly in health care
By
Bernhard Warner
and
Alan Murray
March 28, 2022
Health
Pfizer shares slide after it recalls blood pressure drug over cancer-risk fears
By
Sophie Mellor
March 23, 2022
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By
Andrew Marquardt
March 15, 2022
Health
China just locked down 50 million people amid ‘stealth Omicron’ fears. The former FDA head predicts what happens next
By
Marco Quiroz-Gutierrez
March 15, 2022
International
Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients
By
Riley Griffin
and
Bloomberg
March 14, 2022
Health
Pfizer CEO says new COVID variants might make four—or more—vaccine doses ‘necessary’ for returning to normal
By
Nicholas Gordon
March 14, 2022
Newsletters
Pfizer CEO on cracking COVID: ‘Companies that stay true to their purpose perform far better’
By
Bernhard Warner
and
Alan Murray
March 8, 2022
Health
Scientists have discovered 16 new genetic markers that predispose you to severe illness from COVID
By
Andrew Marquardt
March 7, 2022
Health
The U.S. is about to approve a fourth COVID vaccine that could be a silver bullet solution to the anti-vax crisis
By
Andrew Marquardt
March 7, 2022
Health
Do you need another COVID booster? Here’s what experts say you should do to protect yourself against potential new variants
By
Andrew Marquardt
March 3, 2022
Health
Everyone is planning for a COVID-free summer. But epidemiologists say a new variant could emerge at any time.
By
Tristan Bove
and
Andrew Marquardt
March 1, 2022
Health
How many booster shots will we need?
By
Andrew Marquardt
February 22, 2022
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By
Sasha Rogelberg
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By
Nick Lichtenberg
Success
Less than 10 out of 250 billionaires have kept their promise to give away their fortune—and a philanthropy CEO says...
By
Orianna Rosa Royle